CeriBell, Inc. (CBLL)
CeriBell, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sunnyvale, CA, US. The stock last traded at $21.16, down 0.70% on the session, giving a market capitalisation of $802.9M. On trailing twelve-month figures it carries a trailing P/E of -12.02, a net margin of -64.7%. Its beta of 0.81 implies it has historically moved less than the broad market.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
CeriBell, Inc. is most often compared with the following Healthcare names: